Tumor response assessments with diffusion and perfusion MRI

Sonia P Li1, Anwar R Padhani

  • 1Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, Middlesex, UK.

Insights

Functional imaging techniques like diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) MRI offer superior tumor response assessment compared to anatomic imaging. These methods evaluate cellularity and vascularity, predicting treatment outcomes earlier than traditional scans.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Anatomic imaging has limitations in evaluating tumor response to novel oncologic treatments.
  • Functional imaging offers insights into tumor biology beyond structural changes.

Purpose of the Study:

  • To review diffusion-weighted MRI (DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) as response assessment tools.
  • To discuss the technologies, quantification, validation, and clinical roles of DW-MRI and DCE-MRI.

Main Methods:

  • Focus on DW-MRI and DCE-MRI techniques.
  • Exploration of quantification methods and validation processes for these functional imaging modalities.
  • Review of current applications in assessing response to conventional and novel therapies.

Main Results:

  • Functional imaging (DW-MRI, DCE-MRI) can predict therapy response by assessing tumor cellularity and vascularity.
  • These changes often precede observable morphologic alterations on standard imaging.

Conclusions:

  • DW-MRI and DCE-MRI are valuable for evaluating tumor response to oncologic treatments.
  • Challenges remain in integrating these advanced imaging methods into routine clinical practice.